Ben Graham
Director of Finance/CFO at NEW GUINEA GOLD CORPORATION
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hoyt Edgar Kirby | M | - |
Kirby-Smith Machinery, Inc.
 Kirby-Smith Machinery, Inc. Wholesale DistributorsDistribution Services Kirby-Smith Machinery, Inc. distributes of heavy construction equipment, industrial equipment and cranes. It serves the construction, paving, industrial, aggregate, pipeline/oilfield service, and various other industries. The company was founded by Hoyt Edgar Kirby Jr. in 1983 and is headquartered in Oklahoma City, OK. | 41 years |
| Ces Edward Iewago | M | 64 | 19 years | |
| John Arapidis | M | - |
Kirby-Smith Machinery, Inc.
Kirby-Smith Machinery, Inc. Wholesale DistributorsDistribution Services Kirby-Smith Machinery, Inc. distributes of heavy construction equipment, industrial equipment and cranes. It serves the construction, paving, industrial, aggregate, pipeline/oilfield service, and various other industries. The company was founded by Hoyt Edgar Kirby Jr. in 1983 and is headquartered in Oklahoma City, OK. | 3 years |
| Lachlan Stuart McIntosh | M | 59 | 11 years | |
| Katherine Dunn | F | - |
Kirby-Smith Machinery, Inc.
Kirby-Smith Machinery, Inc. Wholesale DistributorsDistribution Services Kirby-Smith Machinery, Inc. distributes of heavy construction equipment, industrial equipment and cranes. It serves the construction, paving, industrial, aggregate, pipeline/oilfield service, and various other industries. The company was founded by Hoyt Edgar Kirby Jr. in 1983 and is headquartered in Oklahoma City, OK. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Greg Heaney | M | - | 3 years | |
| Matthew Wood | M | 55 | - | |
| John Watson Funder | M | - |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 years |
| Peter Corr | M | 76 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 years |
| Ab Berar | M | - | 7 years | |
| Bryan T. Nethery | M | - | 2 years | |
| Michael Monsour | M | - |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 years |
| Michael William Reynolds | M | 59 | 2 years | |
| Colin B. McKenzie | M | - | 2 years | |
| James Greig | M | - |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 5 years |
| Brian Koster | M | - | - | |
| Thomas Lönngren | M | 73 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | - |
| Betty Loy | F | - | 2 years | |
| Stephen Streeter | M | 68 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 6 years |
| Lisa Hartin | F | - | 2 years | |
| Terje Kalland | M | 73 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 1 years |
| Dennis J. Feeney | M | - |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 7 years |
| Göran Albert Ando | M | 75 |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 years |
| Arthur Alexander | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 21 | 87.50% |
| United States | 3 | 12.50% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ben Graham
- Personal Network
